4.6 Article

Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Exercise and diet modification in non-obese non-alcoholic fatty liver disease: Analysis of biopsies of living liver donors

Young-Joo Jin et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Biochemistry & Molecular Biology

Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients

Miao Hu et al.

JOURNAL OF LIPID RESEARCH (2012)

Article Gastroenterology & Hepatology

Animal Models of Non-Alcoholic Steatohepatitis: Of Mice and Man

J. M. Schattenberg et al.

DIGESTIVE DISEASES (2010)

Article Medicine, General & Internal

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.

Arun J. Sanyal et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Endocrinology & Metabolism

Current treatment of non-alcoholic fatty liver disease

Mohamed H. Ahmed et al.

DIABETES OBESITY & METABOLISM (2009)

Article Cardiac & Cardiovascular Systems

Mechanism of action of niacin

Vaijinath S. Kamanna et al.

AMERICAN JOURNAL OF CARDIOLOGY (2008)

Article Medicine, Research & Experimental

Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice

Catherine Postic et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Review Medicine, General & Internal

Nonalcoholic fatty liver disease as a complication of insulin resistance

Manal F. Abdelmalek et al.

MEDICAL CLINICS OF NORTH AMERICA (2007)

Article Biochemistry & Molecular Biology

Critical role of cholesterol ester transfer protein in nicotinic acid-mediated HDL elevation in mice

Melba Hernandez et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)

Article Medicine, General & Internal

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

Renata Belfort et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Review Medicine, General & Internal

Treatment of non-alcoholic fatty liver disease

LA Adams et al.

POSTGRADUATE MEDICAL JOURNAL (2006)

Review Pathology

Mouse models in non-alcoholic fatty liver disease and steatohepatitis research

QM Anstee et al.

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2006)

Article Gastroenterology & Hepatology

Steatohepatitis induced by intragastric overfeeding in mice

QG Deng et al.

HEPATOLOGY (2005)

Article Biochemistry & Molecular Biology

Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells

SH Ganji et al.

JOURNAL OF LIPID RESEARCH (2004)

Article Biochemistry & Molecular Biology

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease

VT Samuel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Gastroenterology & Hepatology

A Pilot Study of Vitamin E Versus Vitamin E and Pioglitazone for the Treatment of Nonalcoholic Steatohepatitis

Arun J. Sanyal et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)

Review Biochemistry & Molecular Biology

Niacin therapy in atherosclerosis

CD Meyers et al.

CURRENT OPINION IN LIPIDOLOGY (2004)

Article Economics

The price of innovation: new estimates of drug development costs

JA DiMasi et al.

JOURNAL OF HEALTH ECONOMICS (2003)

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver disease

JM Clark et al.

GASTROENTEROLOGY (2002)

Review Medicine, General & Internal

Medical progress - Nonalcoholic fatty liver disease

P Angulo

NEW ENGLAND JOURNAL OF MEDICINE (2002)